FDA Inspection 1103071 — Innoveix Pharmaceuticals Inc
The FDA completed an inspection of Innoveix Pharmaceuticals Inc on Sep 12, 2019 in Addison, TX. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Addison, TX (United States)